Generic Medicine Info
Hypersensitivity. Throat spray: Epiglottitis. Submucosal inj: Use over large areas. Neonates and children.
Special Precautions
Submucosal inj: Select the inj site carefully; not to be given via IV, IM or intrathecal route. Children. Pregnancy and lactation. Patient Counselling Spray/rinse/solution: Do not swallow. As 1.4% spray, 0.6% oral rinse, 29 mg loz: Immediately consult the doctor if the sore throat is severe, persists for >2 days and accompanied or followed by fever, headache, rash, nausea, or vomiting. Topical: Avoid contact with eyes. Do not apply to large areas of the body, deep puncture wounds, animal bites or serious burns. Do not bandage the affected area. As 0.15% paint: Do not use for >7 days unless directed by the doctor. May cause staining of the skin and clothing.
Adverse Reactions
Significant: Submucosal inj: Local ulceration or abscesses, increased systemic absorption and risk of toxic effect (if used over large areas). Rarely, pyrexia, dysuria, transient incontinence, impotence, and prostatic abscess (due to misplaced inj). General disorders and administration site conditions: Inj site pain and discomfort, irritation, ulcer, tissue necrosis (submucosal inj). Hepatobiliary disorders: Hepatitis (submucosal inj). Immune system disorders: Hypersensitivity. Nervous system disorders: Dizziness (submucosal inj). Skin and subcutaneous tissue disorders: Skin irritation, pain, blanching or corrosion (topical).
Potentially Fatal: Submucosal inj: Necrotising fascitis, retroperitoneal sepsis (rare). Throat spray: Rarely, acute epiglottitis, oedema of the epiglottis and/or larynx.
ATC Classification
C05BB05 - phenol ; Belongs to the class of sclerosing agent used as local injection in antivaricose therapy.
N01BX03 - phenol ; Belongs to the class of other agents used as local anesthetics.
D08AE03 - phenol ; Belongs to the class of phenol and derivatives antiseptics. Used in the treatment of dermatological diseases.
R02AA19 - phenol ; Belongs to the class of antiseptics used in throat preparations.
Disclaimer: This information is independently developed by CIMS based on phenol from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in